Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Neoplasms and CXCL10[original query] |
|---|
| Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer. Biomedical reports 2014 May 2 (3): 340-343. Dimberg Jan, Skarstedt Marita, Löfgren Sture, Zar Niklas, Matussek Andre |
| Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism. Cancer biomarkers : section A of Disease markers 2016 Mar . Jafarzadeh A, Fooladseresht H, Nemati M, Assadollahi Z, Sheikhi A, Ghaderi |
| Immunogenetic profiling of 23 SNPs of cytokine and chemokine receptor genes through a minisequencing technique: Design, development and validation. International journal of immunogenetics 2017 Apr . Valverde-Villegas J M, de Medeiros R M, Almeida S E M, Chies J A |
| KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 01 24 (1): 224-233. Lal Neeraj, White Brian S, Goussous Ghaleb, Pickles Oliver, Mason Mike J, Beggs Andrew D, Taniere Philippe, Willcox Benjamin E, Guinney Justin, Middleton Gary |
| Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 12 26 (6): 1474-1485. de la Iglesia Janis V, Slebos Robbert J C, Martin-Gomez Laura, Wang Xuefeng, Teer Jamie K, Tan Aik Choon, Gerke Travis A, Aden-Buie Garrick, van Veen Tessa, Masannat Jude, Chaudhary Ritu, Song Feifei, Fournier Michelle, Siegel Erin M, Schabath Matthew B, Wadsworth J Trad, Caudell Jimmy, Harrison Louis, Wenig Bruce M, Conejo-Garcia Jose, Hernandez-Prera Juan C, Chung Christine |
| Interferon-? signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer. NPJ precision oncology 2019 12 3 32. Cardenas Horacio, Jiang Guanglong, Thomes Pepin Jessica, Parker J Brandon, Condello Salvatore, Nephew Kenneth P, Nakshatri Harikrishna, Chakravarti Debabrata, Liu Yunlong, Matei Danie |
| Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy. Frontiers in genetics 2021 12 646362. Cheng Tianli, Zhang Jing, Liu Danni, Lai Guorong, Wen Xiaopi |
| Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer. Frontiers in genetics 2021 12 632803. Chen Shaojie, Huang Feifei, Chen Shangxiang, Chen Yinting, Li Jiajia, Li Yaqing, Lian Guoda, Huang Kaiho |
| Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer. Therapeutic advances in medical oncology 2021 13 17588359211006680. Katsuta Eriko, Yan Li, Opyrchal Mateusz, Kalinski Pawel, Takabe Kazua |
| Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness. PloS one 2022 8 17 (8): e0273044. Pe Kristine Cate S, Saetung Rattana, Yodsurang Varalee, Chaotham Chatchai, Suppipat Koramit, Chanvorachote Pithi, Tawinwung Supannik |
| Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer. Disease markers 2022 3 2022 5621441. Lv Ji, Ren Jia, Zheng Jie, Zhang Fuliang, Han Me |
| Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases. Clinical colorectal cancer 2023 9 . Ofer Margalit, Sivan Lieberman, Ilanit Redinsky, Sharon Halparin, Nir Honig, Stephen Raskin, Maoz Ben-Ayun, Einat Shacham-Shmueli, Naama Halpern, Damien Urban, Aliza Ackerstein, Katerina Shulman, Eytan Ben-Ami, Valeriya Semenisty, Ofer Purim, Nirit Yarom, Talia Golan, Ben Boursi, Sarit Appel, Zvi Symon, Raanan Berger, David Mauro, Art M Krieg, Yaacov R Lawren |
| CXCL10 and CCL5 as feasible biomarkers for immunotherapy of homologous recombination deficient ovarian cancer. American journal of cancer research 2023 6 13 (5): 1904-1922. Yue Han, Zhewei Guo, Lijuan Jiang, Xinyue Li, Jiahui Chen, Ling Ouyang, Yan Li, Xiaoying Wa |
| Establishment of a prognostic model for melanoma based on necroptosis-related genes. Functional & integrative genomics 2023 6 23 (3): 202. Xiaohui Sui, Xiaodan Zhang, Junde Zhao, Jinxing Liu, Shuling Li, Xiaowen Zhang, Juntao Wa |
| Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer. Disease markers 2023 2 2023 5223657. Gu Cairu, Xiong Xifeng, Liu W |
| Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma. Cancer immunology, immunotherapy : CII 2024 6 73 (8): 141. Yue Zhou, Li Chu, Shuyan Li, Xiao Chu, Jianjiao Ni, Shanshan Jiang, Yechun Pang, Danru Zheng, Yujuan Lu, Fangcen Lan, Xiuyu Cai, Xi Yang, Zhengfei Z |
| Causal relationship between inflammatory factors and gynecological cancer: a Bayesian Mendelian randomization study. Scientific reports 2024 12 14 (1): 29868. Chunxiao Dang, Mengmeng Liu, Pengfei Liu, Jinxing Liu, Xiao Yu, Yan Dong, Junde Zh |
| Investigating the Relationship of G-137C, C-607A, and A-1447G Polymorphisms in the Promoter of IL-18 and CXCL10 Inflammatory Genes with Prostate Cancer in an Iranian Population. Prostate cancer 2024 10 2024 3997576. Nahid Ahmadi, Seyyed Amir Yasin Ahmadi, Abdolreza Kheirollahi, Farhad Shahsav |
- Page last reviewed:Feb 1, 2024
- Content source: